Latest Breaking News On - James jaye bradner - Page 1 : comparemela.com

After seven years as President of NIBR and a member of the ECN, Dr. Bradner will pursue a next chapter of scientific contribution and leadership outside of Novartis Building on NIBR foundation, Dr. Marshall to shape next era of biomedical innovation and continue Novartis leadership in R&D Novartis today announced that James (Jay) E. Bradner, M.D., will step down from the Executive Committee of Novartis (ECN), effective October 31st after seven years leading research at Novartis. Fiona H.

United kingdomFionah marshallJay bradnerFiona marshallJames jaye bradnerRoyal societyMerck co inc in united statesPreclinical developmentNovartis institutes for biomedical researchAcademy of medical sciencesMolecular pharmacology at millennium pharmaceuticalsHonorary fellow of the british pharmacological societyGlobal head of discovery sciencesUniversity of cambridge united kingdomUniversity of bath united kingdomCommittee of novartis